免疫组织化学检测，抗体，程序性死亡配体1
PMA编号：P150013 · 2026-09-21
广告
决定日期2026-09-21
PMA 编号P150013
产品代码PLS
设备分类第3类
医疗专科U
咨询委员会PA
请注意，由于您没有提供具体的医疗设备监管文本，我无法提供准确的翻译。如果您能提供具体的文本内容，我将能够为您提供准确的翻译。
器械摘要
Immunohistochemistry assay, antibody, programmed death-ligand 1 is the device name listed in this FDA 510(k) record. The listed applicant is Agilent Technologies, Inc.. It received FDA 510(k) clearance on 2026-09-21. The device is classified under product code PLS. It was reviewed by the PA advisory panel.
常见问题
What is the Immunohistochemistry assay, antibody, programmed death-ligand 1?
Immunohistochemistry assay, antibody, programmed death-ligand 1 is a medical device that received FDA 510(k) clearance on 2026-09-21. The listed applicant is Agilent Technologies, Inc..
When did Immunohistochemistry assay, antibody, programmed death-ligand 1 receive FDA 510(k) clearance?
The clearance date for Immunohistochemistry assay, antibody, programmed death-ligand 1 can be found in the official FDA records.
免疫组化检测、抗体、程序性死亡配体 1 的申请人是谁？
The FDA 510(k) record lists Agilent Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.
免疫组化检测、抗体、程序性死亡配体1的FDA产品代码是什么？
FDA产品代码为免疫组化检测、抗体、程序性死亡配体1的是PLS。
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告